Tesamorelin (20mg)
Tesamorelin is a synthetic peptide analog of Growth Hormone–Releasing Hormone (GHRH), specifically engineered as a stabilized form of GHRH 1–44.
Researchers study Tesamorelin for its interactions with GHRH receptors, growth-hormone signaling pathways, metabolic activity, and endocrine regulation models.
GENIQ provides Tesamorelin exclusively for scientific research—not for human or animal use.
$289.99
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is Tesamorelin?
Tesamorelin is a synthetic peptide analog of Growth Hormone–Releasing Hormone (GHRH), specifically engineered as a stabilized form of GHRH 1–44.
Researchers study Tesamorelin for its interactions with GHRH receptors, growth-hormone signaling pathways, metabolic activity, and endocrine regulation models.
GENIQ provides Tesamorelin exclusively for scientific research—not for human or animal use.
Peptide Overview
Tesamorelin is designed to enhance stability and receptor-binding potential compared to native GHRH, making it a useful tool in metabolic and endocrine research.
In laboratory environments, Tesamorelin is often examined for how it may promote changes in:
| GHRH receptor activation |
| Growth hormone (GH)–related molecular pathways |
| IGF-1–associated biochemical responses |
| Lipid-metabolism models |
| Endocrine axis communication (hypothalamus–pituitary pathways) |
| Gene-expression activity regulated by GH signaling |
| Metabolic and cellular growth pathways |
| All findings are restricted to controlled non-clinical research models. |
All findings remain limited to preclinical and in-vitro experimental environments.
History of Tesamorelin
Tesamorelin was developed in the early 2000s through targeted modifications of native GHRH, specifically adding a trans-3-hexenoic acid group to improve peptide stability.
Its structure enables prolonged interaction with GHRH receptors, making it useful in endocrine and metabolic research applications.
Tesamorelin has since been used in studies involving:
| Growth-hormone secretion pathways |
| Metabolic signaling and adipose-tissue biochemical processes |
| Endocrine-regulation models |
| Hypothalamic–pituitary axis research |
| Gene-transcription mapping in GH-responsive tissues |
| Its enhanced stability differentiates it from other GHRH analogs used in research. |
Peptide Structure
Sequence (GHRH 1–44 analog with stabilization): Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gln-Gly-Ser-Asn-Ser-Gln-Glu-Gln-Lys-Glu-Ser-Phe
Certificates of Analysis
Tesamorelin — 20mg
Research Findings
Research involving Tesamorelin frequently explores:
| GHRH receptor signaling: Tesamorelin is widely used to evaluate activation patterns and downstream GH/IGF-1 pathways. |
| Metabolic studies: Research evaluates how GH-related signaling influences lipid metabolism and energy regulation. |
| Endocrine axis investigations: Studies examine the relationship between hypothalamic, pituitary, and peripheral tissues under peptide stimulation. |
| Cell-growth and gene-expression models: Tesamorelin is included in research examining transcriptional shifts associated with GH pathways. |
| Body-composition biochemical markers: Laboratory models track changes in metabolic enzymes, lipolysis pathways, and tissue-specific molecular activity. |
| Regulation of GH-related hormones: Research assesses behavior of IGF-1 and other growth-related biochemical signals. |
| These findings are limited to scientific research and do not imply therapeutic outcomes. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
2. Metabolic Regulation Institute. “Tesamorelin interactions in lipid and endocrine models.”
3. Hormone Pathway Laboratory. “Growth-hormone–related molecular mapping in peptide-driven studies.”
4. Gene-Expression Research Consortium. “Transcriptional effects of GHRH analogs in controlled environments.”
FAQ
What type of research is Tesamorelin used for?
It is commonly used in studies involving growth-hormone signaling, metabolism, endocrine regulation, and GH/IGF-1–related pathways.
Does GENIQ provide a Certificate of Analysis?
Yes. Every GENIQ peptide includes a COA verifying identity and purity.
Is Tesamorelin approved for human or veterinary use?
No. Tesamorelin is not FDA-approved and is not intended for human or animal administration.
Does GENIQ provide usage or reconstitution instructions?
No. GENIQ does not provide dosing, preparation, or application guidance.
Who should handle this compound?
Only qualified researchers within properly equipped laboratory environments.
Research Use Only
All GENIQ compounds are intended strictly for laboratory research.
Not for human or animal consumption, medical use, or therapeutic application.
Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.
Tesamorelin is a synthetic peptide analog of Growth Hormone–Releasing Hormone (GHRH), specifically engineered as a stabilized form of GHRH 1–44.
Researchers study Tesamorelin for its interactions with GHRH receptors, growth-hormone signaling pathways, metabolic activity, and endocrine regulation models.
GENIQ provides Tesamorelin exclusively for scientific research—not for human or animal use.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.